IL58489A0 - The production of oxymorphone - Google Patents

The production of oxymorphone

Info

Publication number
IL58489A0
IL58489A0 IL58489A IL5848979A IL58489A0 IL 58489 A0 IL58489 A0 IL 58489A0 IL 58489 A IL58489 A IL 58489A IL 5848979 A IL5848979 A IL 5848979A IL 58489 A0 IL58489 A0 IL 58489A0
Authority
IL
Israel
Prior art keywords
oxymorphone
production
Prior art date
Application number
IL58489A
Other languages
English (en)
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of IL58489A0 publication Critical patent/IL58489A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polarising Elements (AREA)
IL58489A 1978-10-19 1979-10-18 The production of oxymorphone IL58489A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19

Publications (1)

Publication Number Publication Date
IL58489A0 true IL58489A0 (en) 1980-01-31

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58489A IL58489A0 (en) 1978-10-19 1979-10-18 The production of oxymorphone

Country Status (16)

Country Link
JP (1) JPS55501025A (da)
AU (1) AU5189779A (da)
BE (1) BE879494A (da)
CA (1) CA1108132A (da)
CS (1) CS211364B2 (da)
DK (1) DK258280A (da)
ES (1) ES485154A1 (da)
FI (1) FI793235A7 (da)
FR (1) FR2439201A1 (da)
GB (1) GB2049680A (da)
IL (1) IL58489A0 (da)
IT (1) IT7969032A0 (da)
NL (1) NL7920126A (da)
NO (1) NO793297L (da)
SE (1) SE8004454L (da)
WO (1) WO1980000841A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) * 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
CA2067200C (en) * 1989-10-16 1998-06-30 Kenner C. Rice Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
DE60223254T2 (de) 2001-07-06 2008-08-14 Penwest Pharmaceuticals Co. Verzögert freisetzende formulierungen von oxymorphon
JP2005515966A (ja) 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ， インコーポレイティド 鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CN101395159A (zh) 2006-03-02 2009-03-25 马林克罗特公司 制备含有低含量α,β-不饱和酮化合物的吗啡烷-6-酮产物的方法
CA2713128C (en) 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
AU2009243681B2 (en) 2008-05-09 2013-12-19 Grunenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
CN102639118B (zh) 2009-07-22 2015-07-29 格吕伦塔尔有限公司 氧化稳定的抗干扰剂型
KR101738369B1 (ko) 2009-07-22 2017-05-22 그뤼넨탈 게엠베하 핫 멜트 압출된 제어 방출 투여형
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
BR112013005194A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo sal inorgânico
BR112014001091A2 (pt) 2011-07-29 2017-02-14 Gruenenthal Gmbh comprimido resistente à adulteração que fornece liberação imediata do fármaco
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
EP2838512B1 (en) 2012-04-18 2018-08-22 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
EP3003279A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
EP3252055B1 (en) 2016-05-31 2018-09-19 Alcaliber Investigacion Desarrollo e Innovacion SLU Process for obtaining 3,14-diacetyloxymorphone from oripavine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
ES485154A1 (es) 1980-06-16
GB2049680A (en) 1980-12-31
NL7920126A (nl) 1980-08-29
NO793297L (no) 1980-04-22
BE879494A (fr) 1980-02-15
JPS55501025A (da) 1980-11-27
FI793235A7 (fi) 1981-01-01
WO1980000841A1 (en) 1980-05-01
CS211364B2 (en) 1982-02-26
CA1108132A (en) 1981-09-01
AU5189779A (en) 1980-04-24
IT7969032A0 (it) 1979-10-18
FR2439201A1 (fr) 1980-05-16
SE8004454L (sv) 1980-06-16
DK258280A (da) 1980-06-17

Similar Documents

Publication Publication Date Title
IL58489A0 (en) The production of oxymorphone
GB2017101B (en) Production of maytansinoids
JPS54105273A (en) Production of riceecracker
JPS5523999A (en) Production of 66aminoo 66deoxyyllsolbose
JPS54109932A (en) Manufacture of fluorobenzol
GB2015992B (en) Manufacture of para-nitro-diphenylamines
JPS54132575A (en) Manufacture of tetrahydrobenzoxocin
GB2012276B (en) Producing cephalosporins
GB2015997B (en) Production of nitrodiarylamines
GB2022083B (en) Production of iso-alpha-acids
JPS54109924A (en) Manufacture of silylphosphate
JPS54163538A (en) Production of salycilaldehydes
GB2015427B (en) Production of laminates
IL56245A0 (en) 8-alkyl-substituted morphinan-6-one compounds and their production
JPS54100322A (en) Manufacture of nnacyltaurine
JPS54131600A (en) Manufacture of borazin
JPS54122243A (en) Manufacture of 22nitrobenzaldehyde
IL58568A (en) Manufacture of 5-cyano-4-methyloxazole
JPS54143495A (en) Production of polyvinylpyrolidoneeiodine
IL58941A (en) Production of phenyl-2-fluoroacrylate
JPS54128530A (en) Manufacture of ppaminoodiphenylamine
IL57174A (en) Manufacture of alpha-chloroacetoacetamides
GB2014178B (en) Halogenoantyraquinone compounds and the production and usethereof
JPS54117412A (en) Manufacture of 22nitroo22methyll11propanol
JPS54112858A (en) Manufacture of 22pyrrolidone